Key Takeaways
- Oracle shares have tumbled approximately 29% year-to-date through early April 2026, even as the company posts impressive revenue gains.
- Third-quarter fiscal 2026 revenue reached $17.2 billion, representing 22% year-over-year growth and exceeding analyst forecasts.
- The company’s remaining performance obligations (RPO) backlog jumped to $553 billion from $455 billion six months prior in September 2025.
- Oracle intends to allocate $50 billion toward capital expenditures in FY2026 and secure an additional $50 billion via debt and equity financing.
- Wall Street analysts remain divided, with price projections spanning $160 to $400, underscoring conflicting views on when free cash flow will materialize.
Oracle has emerged as one of Wall Street’s most perplexing narratives in 2026. While the company continues to post robust revenue expansion and build an unprecedented backlog, shares have declined nearly one-third since the start of the year. This disconnect has sparked heated debate among market watchers.
The enterprise software giant delivered fiscal third-quarter 2026 revenue of $17.2 billion, marking a 21.7% year-over-year increase that surpassed Wall Street’s $16.91 billion estimate. Adjusted earnings per share reached $1.79, topping the $1.71 consensus forecast. Management also raised its fiscal 2027 revenue guidance to $90 billion.
The contracted revenue pipeline paints an even more dramatic picture. Remaining performance obligations soared to $553 billion by March 2026, representing a significant jump from $455 billion recorded six months earlier. This massive backlog reflects substantial future revenue already locked in through contracts.
Yet investors remain skeptical. Why?
The Price Tag of Rapid Expansion
Oracle has disclosed expectations for fiscal 2026 capital spending to hit $50 billion — representing more than a doubling from the previous year. Additionally, management revealed plans to secure another $50 billion through a combination of debt and equity offerings to finance cloud infrastructure buildout. The company’s debt burden already stood at approximately $100 billion by December 2025.
This significant financial obligation has investors scrutinizing cash generation metrics, particularly given that investment returns from this infrastructure spending will take considerable time to materialize.
Melius analyst Ben Reitzes downgraded the stock to Hold in February, establishing a $160 price target. His rationale centers on the view that Oracle deserves valuation multiples closer to infrastructure companies rather than traditional software firms — particularly since meaningful free cash flow generation may not occur until the 2030s, eliminating justification for software-level premium valuations.
Compounding investor concerns, Oracle implemented workforce reductions affecting roughly 30,000 employees through mass email notifications, a decision that may reduce short-term expenses but has raised questions about operational execution and company culture.
The Bull-Bear Divide
Not all analysts share this pessimistic outlook. JPMorgan upgraded Oracle to Overweight in March, setting a $210 price target while characterizing the selloff as “drastic” and suggesting the risk-reward balance had improved significantly more than underlying business fundamentals had deteriorated.
Mizuho analyst Siti Panigrahi maintained her Buy rating while adjusting her price target downward from $400 to $320. She highlighted Oracle’s cloud infrastructure as uniquely defensible against competitor offerings. Panigrahi also noted an emerging trend in enterprise AI adoption — companies increasingly prefer bringing AI capabilities to their existing data repositories rather than migrating data to new platforms, a dynamic that favors Oracle’s positioning.
KeyBanc’s Jackson Ader retained his Overweight rating with a $300 target, framing Oracle as a comprehensive AI investment spanning infrastructure, applications, and data capabilities. The company’s recently launched Fusion Agentic Applications — designed for finance, human resources, supply chain management, and customer experience functions — represent a cornerstone of this investment thesis.
Regarding insider activity, Executive Vice President Douglas Kehring divested 35,000 shares in January at approximately $194.89 per share, reducing his stake by roughly 51%. CEO Clayton Magouyrk sold 10,000 shares in February at $155.23. Company insiders collectively control 40.9% of outstanding shares.
As of early April, ORCL opened trading at $138.00, significantly below its 52-week peak of $345.72 and approaching its 52-week floor of $121.24. The consensus analyst price target currently stands at $260.71, suggesting considerable upside potential — assuming the optimistic timeline projections prove accurate.
